Adhera Therapeutics, Inc. (ATRX)

Market Cap	1.16K -99.7%
Revenue (ttm)	n/a
Net Income	-4.61M
EPS	-1.31
Shares Out	11.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6,285
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0000 - 0.0100
Beta	809.71
RSI	46.34
Earnings Date	n/a

About Adhera Therapeutics

Adhera Therapeutics, Inc., a biotech company, focuses on the discovery, development, and commercialization of small molecule drugs. The company is developing MLR-1019 for the treatment of Parkinson’s disease; and MLR -1023 to treat Type 1 diabetes. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

• Industry: Biotechnology
• Sector: Healthcare
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: ATRX